Want to add more growth to your portfolio but not sure where to look? Companies such as Medlab Clinical and Nearmap are deemed high-growth by the market, with a positive outlook in all areas – returns, profitability and cash flows. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.

Medlab Clinical Limited (ASX:MDC)

Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. Formed in 2012, and now led by CEO Sean Hall, the company employs 14 people and with the market cap of AUD A$116.16M, it falls under the small-cap category.

Driven by exceptional sales, which is expected to more than double over the next few years, MDC is expected to deliver an excellent earnings growth of 79.42%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 45.54%. MDC ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Could this stock be your next pick? Check out its fundamental factors here.

Nearmap Ltd (ASX:NEA)

Nearmap Ltd provides online aerial photomapping services in Australia and the United States. The company was established in 2000 and with the company’s market capitalisation at AUD A$242.79M, we can put it in the small-cap group.

Driven by the exceptional 67.77% sales growth over the next few years, NEA is expected to deliver an excellent earnings growth of 68.13%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 23.27%. NEA ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Want to know more about NEA? Take a look at its other fundamentals here.

Animoca Brands Corporation Limited (ASX:AB1)

Animoca Brands Corporation Limited develops and markets a portfolio of mobile games for smartphones and tablets worldwide. The company employs 125 people and with the stock’s market cap sitting at AUD A$5.47M, it comes under the small-cap category.

Driven by exceptional sales, which is expected to more than double over the next few years, AB1 is expected to deliver an excellent earnings growth of 94.23%. It appears that AB1’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 26.91%. AB1 ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. A potential addition to your portfolio? I recommend researching its fundamentals here.

For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.